{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:40:08Z","timestamp":1751053208022,"version":"3.41.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s13312-025-00075-9","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T11:29:20Z","timestamp":1745321360000},"page":"501-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabidiol in Drug-Resistant Epilepsy (DRE) in Children: A Retrospective Study"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-0492","authenticated-orcid":false,"given":"Vykuntaraju K.","family":"Gowda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halima","family":"Simin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uddhava V.","family":"Kinhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. V.","family":"Basavaraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Sanjay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"75_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug-resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51:1069\u201377.","journal-title":"Epilepsia"},{"key":"75_CR2","first-page":"89","volume":"17","author":"J Nasiri","year":"2023","unstructured":"Nasiri J, Ghazzavi M, Sedghi M, et al. Causes and risk factors of drug-resistant epilepsy in children. Iran J Child Neurol. 2023;17:89\u201397.","journal-title":"Iran J Child Neurol"},{"key":"75_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12883-023-03508-9","volume":"24","author":"OH Urio","year":"2024","unstructured":"Urio OH, Kija E, Weckhuysen S, et al. Drug-resistant epilepsy and associated factors among children with epilepsies in Tanzania: a cross-sectional study. BMC Neurol. 2024;24:8.","journal-title":"BMC Neurol"},{"key":"75_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1055\/s-0043-1768658","volume":"12","author":"VK Gowda","year":"2023","unstructured":"Gowda VK, Thavalenga J, Nanjundappa RC. Study on effectiveness and tolerability of adjunctive perampanel treatment in children with refractory epilepsy in a tertiary care center. J Pediat Epilep. 2023;12:98\u2013102.","journal-title":"J Pediat Epilep"},{"issue":"Pt B","key":"75_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.yebeh.2017.02.005","volume":"70","author":"AS Suraev","year":"2017","unstructured":"Suraev AS, Todd L, Bowen MT, et al. An Australian nationwide survey on medicinal cannabis use for epilepsy: history of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy Behav. 2017;70(Pt B):334\u201340.","journal-title":"Epilepsy Behav"},{"key":"75_CR6","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","volume":"78","author":"S Lattanzi","year":"2018","unstructured":"Lattanzi S, Brigo F, Trinka E, et al. Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. Drugs. 2018;78:1791\u2013804.","journal-title":"Drugs"},{"key":"75_CR7","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.3390\/molecules28073271","volume":"28","author":"J Castillo-Arellano","year":"2023","unstructured":"Castillo-Arellano J, Canseco-Alba A, Cutler SJ, et al. The polypharmacological effects of cannabidiol. Molecules. 2023;28:3271.","journal-title":"Molecules"},{"key":"75_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5603\/PJNNS.a2022.0020","volume":"56","author":"M Mazurkiewicz-Be\u0142dzi\u0144ska","year":"2022","unstructured":"Mazurkiewicz-Be\u0142dzi\u0144ska M, Zawadzka M. Use of cannabidiol in the treatment of epilepsy. Neurol Neurochir Pol. 2022;56:14\u201320.","journal-title":"Neurol Neurochir Pol"},{"key":"75_CR9","unstructured":"Meissner H, Cascella M. Cannabidiol (CBD). In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2025. Accessed on Feb 27, 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556048\/"},{"key":"75_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","volume":"15","author":"O Devinsky","year":"2016","unstructured":"Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15:270\u20138.","journal-title":"Lancet Neurol"},{"key":"75_CR11","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet Syndrome. N Engl J Med. 2017;376:2011\u201320.","journal-title":"N Engl J Med"},{"key":"75_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pediatrneurol.2023.10.012","volume":"150","author":"M Tzadok","year":"2024","unstructured":"Tzadok M, Gur-Pollack R, Florh H, et al. Real-life experience with purified cannabidiol treatment for refractory epilepsy: a multicenter retrospective study. Pediatr Neurol. 2024;150:91\u20136.","journal-title":"Pediatr Neurol"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-025-00075-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:08:44Z","timestamp":1751051324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-025-00075-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1007\/s13312-025-00075-9","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"type":"print","value":"0019-6061"},{"type":"electronic","value":"0974-7559"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"13 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Waiver from IEC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"ECR\/441\/Inst\/KA\/2013\/RR-19 dated Oct 30, 2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}